Robert Lanza, M.D. is considered one of the leading scientists in the world. He was born in Boston, Massachusetts in February, 1956 and is currently Chief Scientific Officer at Advanced Cell Technology (ACT) (OTCBB:ACTC.OB), a pioneer of embryonic  stem cell research. Dr. Robert Lanza is also an Adjunct Professor at the Institute for Regenerative Medicine, [...]

As any experienced CEO will acknowledge, you can never save a company by cutting expenses alone. Republicans, with their newly found status in the U.S. Congress, and now democrats alike are focused on reducing the budget deficit and doing so in a dramatized manner for political gain along the way.   Perhaps with all good intentions, [...]

The Food and Drug Administration (FDA) recently presented its ideas and somewhat of an ad campaign for continued deterrence of smoking.  The primary elements of their campaign ideas consist of requiring cigarette makers to print bold and extreme graphic health warnings on cigarette packages and billboard advertisements. Their newfound power of regulating tobacco (The Family [...]

Eli Lilly & Co. (LLY), the 10th largest pharmaceutical company in the world, recently obtained approval to sell the antidepressant drug, Cymbalta, as a pain killer. The Food and Drug Administration (FDA) cleared Cymbalta for remedies for arthritis and chronic lower back conditions. As with most drug firms, Lilly is playing the game of patent [...]

In early 2009, the Obama Administration lifted the ban for federal funding for certain types of embryonic stem-cell research that had originally been imposed by the Bush administration in 2001. The move indicated a boon for companies, federal funding, and respective stocks related to the stem cell industry.  Any company involved in embryonic stem-cell research [...]